The prevalence of insulin receptor antibodies in patients with systemic lupus erythematosus and related conditions

Journal of Clinical Rheumatology

Volumn 7, Issue 6, 2001, Pages 371-373

  Rosenstein, E D ^a   Advani, S ^a   Reitz, R E ^a   Kramer, N ^a  

^a Arthritis and Rheumatic Disease Ctr   (United States)

Author keywords

Anti insulin receptor antibodies; Diabetes mellitus; Insulin receptor; Systemic lupus erythematosus

Indexed keywords

INSULIN RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; INSULIN RESISTANCE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0035654797     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200112000-00004     Document Type: Article

References (10)

1. Diseases caused by antibodies to receptors
2. Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors
3. Refractory hyperglycemia complicating an evolving connective tissue disease: Response to cyclosporine
4. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE)
5. Early undifferentiated connective tissue disease. IV. Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: Follow-up analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline
6. Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosus
7. Prevalence of abnormal thyroid function tests in connective tissue disease
8. Thyroid peroxidase autoantibodies and their effects on enzyme activity in patients with systemic lupus erythematosus
9. A connective tissue disease complicated by insulin resistance due to receptor antibodies
10. Hypoglycemia due to antiinsulin receptor antibodies in systemic lupus erythematosus